Successful Treatment of Iron Overload by Phlebotomies in a Patient With Severe Congenital Dyserythropoietic Anemia Type II by W.K. Hofmann, J.P. Kaltwasser,

Slides:

Advertisements

Similar presentations

CU-1 Iron Overload: Complications and Need for Therapy John B. Porter, MD Professor of Hematology University College, London, UK.

Advertisements

An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe −/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase–deficient children receiving dapsone by Allan Pamba, Naomi D. Richardson,

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Kamyar Kalantar-Zadeh Kidney International

Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta.

The influence of high-altitude living on body iron

The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.

by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and

Navneet S. Majhail, Todd DeFor, Hillard M. Lazarus, Linda J. Burns

Genetic Heterogeneity of Congenital Dyserythropoietic Anemia Type II

Exclusion of Three Candidate Genes as Determinants of Congenital Dyserythropoietic Anemia Type II (CDA-II)‏ by Achille Iolascon, Emanuele Miraglia del.

Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.

Finding a diamond in the (mouse is) rough

Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis by Shameem Mahmood, Julie Blundell,

Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease Martin et al. Am J Nephrol 2017;45: (DOI:

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

New options for the anemia of chronic kidney disease

Iron-Chelating Therapy and the Treatment of Thalassemia

Tax fingerprint in adult T-cell leukemia

How I treat elderly patients with myeloma

Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,

by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu

Autologous Transplantation Therapy for Chronic Myelogenous Leukemia

An Unusual Cause of Abdominal Pain in Sickle Cell Disease

Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children by Ayami Yoshimi, Charlotte.

Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis by Lisa A. Michaels, Kwaku.

What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):

Hemoglobin levels in African-Americans

In situ identification of allospecific B cells using pentamers

A Prospective Study of Iron Overload Management in Allogeneic Hematopoietic Cell Transplantation Survivors Navneet S. Majhail, Hillard M. Lazarus, Linda.

Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein,

by John C. Wood, Pinggao Zhang, Hugh Y

by Alexander Röth, Andreas Hüttmann, Russell P

Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients.

by Natalie J. Foot, Yew Ann Leong, Loretta E. Dorstyn, Hazel E

by James D. Cook, Carol H. Flowers, and Barry S. Skikne

by Sabah Sallah, and Jim Y. Wan

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

Anergy: the CLL cell limbo

Navneet S. Majhail, Todd DeFor, Hillard M. Lazarus, Linda J. Burns

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.

Timothy S. Collins, MD, Murat O. Arcasoy, MD

Chronic graft-versus-host disease

Kamyar Kalantar-Zadeh Kidney International

by Achille Iolascon, Hermann Heimpel, Anders Wahlin, and Hannah Tamary

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Iron Overload Manifesting as Apparent Exacerbation of Hepatic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation Rammurti.

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Plasma biomarker concentrations between study groups.

Erythropoietin and iron

Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.

by Wendy Lim, Sara K. Vesely, and James N. George

Iron Overload in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: Quantification of Iron Burden by a Superconducting Quantum Interference.

Overcoming “aspirin resistance” in MPN

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

RBC counts (A), hemoglobin (B), MCH (C), serum transferrin (Tf) saturation (D), and serum ferritin (E) in 47 pregnant women (study 1) divided according.

Treatment algorithm for management of CRS based on the revised CRS grading system. Treatment algorithm for management of CRS based on the revised CRS grading.

How I treat thrombocytopenia in pregnancy

Rituximab immunotherapy: it’s getting personal

by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio

Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation Philippe Armand, Haesook T. Kim, Joanna Rhodes,

Diagnoses in patients with TA-GVHD.

Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia by Mohamed Bradai, Mohand Tayeb Abad, Serge Pissard, Fatima Lamraoui,

Cold agglutinin disease

Study protocol. Study protocol. All participants were studied on four occasions: Twice before and twice after an 8-wk treatment period on low-dosage, low.

Effect of aspirin (ASA) on serum cytokine concentration in hemodialysis (HD) patients. Effect of aspirin (ASA) on serum cytokine concentration in hemodialysis.

Presentation transcript:

Successful Treatment of Iron Overload by Phlebotomies in a Patient With Severe Congenital Dyserythropoietic Anemia Type II by W.K. Hofmann, J.P. Kaltwasser, D. Hoelzer, P. Nielsen, and E.E. Gabbe Blood Volume 89(8):3068-3068 April 15, 1997 ©1997 by American Society of Hematology

Hb and serum ferritin concentrations during phlebotomy in the patient suffering from CDA II. Liver iron concentration (per gram wet weight) as measured by biomagnetometry is given in bars. Hb and serum ferritin concentrations during phlebotomy in the patient suffering from CDA II. Liver iron concentration (per gram wet weight) as measured by biomagnetometry is given in bars. Stepwise increase of removed blood in weeks 1 through 4 (see text). W.K. Hofmann et al. Blood 1997;89:3068 ©1997 by American Society of Hematology